InvestorsHub Logo

GoodGuyBill

08/13/19 1:24 AM

#239489 RE: Umibe5690 #239488

I think many shareholders would be happy with a buck or two BO and call it a day.

photonic5

08/13/19 5:20 AM

#239499 RE: Umibe5690 #239488

You should think again about how 4 RAs affect and influence the FDA. A safe and effective approved DCVAX therapy for GBM in the U.K. and Europe could lead to a survival discrepancy across continents. This would eventually undermine the business of American medicine as people would seek treatment exclusively in Europe for GBM. That’s a bad look on the FDA.